The relation between intrauterine growth and risk of childhood acute lymphoblastic leukemia was investigated in an Australian population-based case-control study that included 347 cases and 762 controls aged <15 years recruited from 2003 to 2006. Information on proportion of optimal birth weight, a measure of the appropriateness of fetal growth, was collected from mothers by questionnaire. Data were analyzed by using logistic regression. Risk of acute lymphoblastic leukemia was positively associated with proportion of optimal birth weight; the odds ratio for a 1-standard-deviation increase in proportion of optimal birth weight was 1.18 (95% confidence interval: 1.04, 1.35) after adjustment for the matching variables and potential confounders. This association was also present among children who did not have a high birth weight, suggesting that accelerated growth, rather than high birth weight per se, is associated with risk of acute lymphoblastic leukemia. Similar associations between proportion of optimal birth weight and acute lymphoblastic leukemia were observed for both sexes and across age groups and leukemia subtypes. Results of this study confirm earlier findings of a positive association between rapidity of fetal growth and subsequent risk of acute lymphoblastic leukemia in childhood, and they are consistent with a role for insulin-like growth factors in the causal pathway. birth weight; case-control studies; child; fetal development; leukemia; precursor cell lymphoblastic leukemia-lymphoma Abbreviations: ALL, acute lymphoblastic leukemia; IGF-I, insulin-like growth factor I; POBW, proportion of optimal birth weight.
Leukemia is the commonest childhood malignancy, accounting for about 35% of childhood cancer cases diagnosed in developed countries. Despite extensive research, little is known about its etiology. Its early age at onset has focused attention on in utero and perinatal factors, and birth weight has consistently been found to be associated with risk of acute lymphoblastic leukemia (ALL). A 2003 meta-analysis reported a pooled odds ratio of 1.26 (95% confidence interval: 1.17, 1.37) for birth weight over 4,000 g (1) , and most subsequent studies (2-10) have reported increasing risk of ALL with increasing birth weight.
Few studies of ALL have taken account of gestational age in the analysis of birth weight. Because birth weight is a function of both intrauterine growth and length of gestation, it is not possible to differentiate between an association with high birth weight per se and an association with accelerated intrauterine growth unless gestational age is accounted for. If there were an association with accelerated growth, the risk would extend to infants born at any gestational age who had a higher-than-expected birth weight for their gestational age, whether or not they were considered to be of ''high birth weight'' in the absolute sense. Such an association would suggest that factors such as exposure to high levels of growth hormones might be etiologically important. On the other hand, a different causal mechanism is likely if the association was with high birth weight per se. For example, because birth weight is positively associated with bone marrow volume (11, 12) , heavier children may simply have more cells at risk of malignant transformation (13) . Clarifying the nature of the relation between fetal growth and risk of ALL will assist in elucidating causal pathways.
We recently reported a moderately strong, positive association between the risk of ALL and proportion of optimal birth weight (POBW) in a study using linked medical records (14) . This finding is consistent with higher levels of circulating growth factors increasing ALL risk. In this study, however, we had limited information on ethnicity and, for the majority of participants, no information on maternal smoking or socioeconomic status. Furthermore, no information was available about the cytogenetic characteristics or immunophenotype of the leukemia.
The aim of the current study was to investigate the association between the appropriateness of intrauterine growth and ALL risk in a population-based study. For our study, detailed demographic information and maternal smoking history were available, and subgroup analyses for specific ALL subtypes could be undertaken.
MATERIALS AND METHODS

Study population
The Australian Study of Causes of Acute Lymphoblastic Leukaemia in Children was a national, population-based, multicenter, case-control study that investigated genetic, dietary, and environmental risk factors for ALL, and their interactions. Therefore, only those children whose biologic mother was available and had adequate English skills were eligible to participate.
Case families were identified through all 10 pediatric oncology centers in Australia, where virtually all children with ALL are treated. In the 2 complete years of recruitment for which registry data are available (2004 and 2005) , no cases were registered as having been diagnosed and/or treated outside the participating hospitals (Australian Paediatric Cancer Registry, February 2009, personal communication). Cases were eligible to participate if they were diagnosed between July 1, 2003, and December 31, 2006 , and achieved initial remission. The oncologist at each center explained the study to the parents, gave them an information sheet, and obtained their written consent. Controls were recruited by national random digit dialing in 7 waves between August 2003 and October 2006 by a survey research contractor. Once parents agreed to be contacted, information sheets and consent forms were mailed to their home. When necessary, return of the consent forms was prompted by telephone. Controls were frequency matched to cases by age (within 1 year), sex, and Australian state of residence, and 2 controls were recruited per case. The study was approved by the 10 hospital research ethics committees.
Information was collected in mailed questionnaires about medical and residential histories of the parents and child and their engagement in activities potentially involving exposure to carcinogenic agents. Parents also completed telephone interviews about specific occupational exposures and were sent food frequency questionnaires. If parents did not complete the exposure questionnaire or food frequency questionnaire, they were asked to provide demographic information and key exposure information in a brief telephone interview.
Our primary explanatory variable in this analysis was POBW-the ratio of observed birth weight to ''optimal birth weight'' at the estimated gestational age at birth (15) . Optimal birth weight is calculated from a regression equation including terms for gestational age, maternal height, parity, and infant sex that was derived from a population of singleton births without any recorded risk factors for intrauterine growth restriction. Maternal height is included in the regression equation because it is strongly correlated with uterine surface area available for placentation and thus for fetal blood supply. The data required to calculate optimal birth weight were reported in the mothers' selfadministered questionnaires or telephone interviews. POBW is similar to the ratio of observed to expected weight for gestational age, with optimal birth weight substituted for expected weight.
Children with birth defects-including Down syndromewere excluded from the analyses because of the potential for confounding of the relation between ALL risk and POBW. Having a birth defect is known to be related to both fetal growth and risk of ALL.
Statistical analysis
Logistic regression analysis in STATA version 10 software (StataCorp, College Station, Texas) was used to investigate the association between POBW and ALL risk. POBW was included as a continuous variable, and preliminary analyses showed that it should be modeled in linear form. Odds ratios for a 10% increase and a 1-standard-deviation increase were estimated, along with 95% confidence intervals.
All models were adjusted for the study matching factors: age, sex, and state of residence. Variables considered a priori to be potential confounders of the association between POBW and risk of ALL were assessed for inclusion in the models; included were ethnicity, maternal age at child's birth, maternal smoking during pregnancy, family income, parental education, and source of maternal height data. The likelihood ratio test was used to assess improvement in the fit resulting from including these variables in the multivariable models (P < 0.05). Unless otherwise indicated, all odds ratios were also adjusted for maternal age at child's birth, parental education, and source of maternal height data. The ethnic background of cases and controls was similar (Table 1) , and its inclusion in the analytical models did not change the estimated odds ratios; thus, it was excluded.
Because the risk of ALL varies with age and sex, odds ratios were calculated separately for each sex and for 4 age groups: 0-1, 2-4, 5-9, and 10-14 years. Differences in the association between POBW and ALL by age group and sex were formally tested by fitting interaction terms in the model.
We repeated the main analyses by considering children who were not of ''high birth weight'' in conventional terms (using 2 alternative definitions of high birth weight: >3,500 g and >4,000 g) and among cytogenetic and immunophenotypic subtypes of ALL. We also examined the association between risk of ALL and birth weight-with and without adjustment for gestational age-to permit comparison with previous studies. Birth weight was modeled initially as a continuous variable and then as the binary outcome ''high birth weight,'' defined as either >3,500 g or >4,000 g.
RESULTS
We were notified of 568 incident ALL cases, of whom 49 were ineligible to participate: 30 from a non-English-speaking background, 12 who were overseas visitors, 3 whose biologic mother was unavailable, and 4 who did not achieve remission. Of the families of 519 eligible cases, 416 (80.2%) consented to participate, and 377 (91.0% of those consenting, 72.6% of those eligible) provided the information required to calculate POBW. Of the 2,947 eligible control families identified through random digit dialing, 2,071 (70.3%) agreed to take part. Because of frequency-matching quotas, we recruited only 1,361 of these families to the study. Of these recruited families, 1,249 (91.8%) completed the self-administered questionnaire or brief telephone interview. Because the latter did not request information on the child's gestational age (required for the calculation of POBW), 379 controls were unable to be included. For an additional 63, one or more required variables (gestational age, maternal height, or child's birth weight) were missing, leaving 807 (59.3%) controls available for analysis. The final data set contained 347 cases and 762 controls, after exclusion of 22 cases and 25 controls with birth defects and 8 cases and 20 controls from multiple births ( Table 1) . The distributions of demographic and other variables of interest were generally similar among cases and controls ( Table 1 ). The main differences were that a higher proportion of parents of controls than parents of cases had a tertiary education, and a higher proportion of mothers of controls were aged 35 years or older at the time the index child was born. There was little difference in their household income distributions. The source of maternal height data also differed between cases and controls; a higher proportion of parents of cases than parents of controls completed the written questionnaires, while a higher proportion of the latter completed a brief telephone interview. Mean birth weights of cases and controls were similar, whereas mean POBW was higher among the cases. There were relatively small differences between cases and controls with regard to gestational age, maternal height, and birth order; these differences were accounted for because all 3 variables are included in the calculation of POBW.
After adjusting for the matching variables age, sex, and state of residence, a 10% increase in POBW was associated with a 14% increase in ALL risk, and an increase of 1 standard deviation (13%) in POBW was associated with a 19% increase in risk (Table 2) . Adjustment for other potential confounding variables produced little change in these estimates (Table 2) . Furthermore, the odds ratios varied little by age or sex (data not shown), and the P values for the age 3 POBW and sex 3 POBW interaction terms were 0.42 and 0.58, respectively. When analyses were restricted to children who did not have a ''high birth weight,'' defined as either >3,500 g or >4,000 g, the associations appeared to be stronger (Table 2) .
Positive associations between POBW and risk of ALL were observed for both the pre-B and T-cell immunophenotypes (Table 3) . Odds ratios consistent with an increasing risk of ALL with increasing POBW were also observed for most cytogenetic subtypes and for cases with a normal karyotype (Table 3) . A notable exception was the ''MLL gene rearrangements'' category, where the result was suggestive of an inverse association with POBW. There was also only a slight increase in risk with hypodiploidy and other numerical changes (in chromosomes) other than trisomy or greater at chromosome 21. However, most of the estimated odds ratios for subtypes lacked precision because of small numbers of cases.
Our analysis of the association between risk of ALL and birth weight showed some positive associations, but only e ''Other structural change'' defined as any structural change that is neither a translocation nor a deletion, such as isochromosomes or abnormal derivative chromosomes.
f Included in the analysis were 607 controls because 1 Australian state had no cases of ALL in this subcategory; therefore, 155 controls from that state were excluded. g Refers to somatic (not constitutive) changes in tumor cells; children with Down syndrome were excluded from the study.
h ''Other numerical change'' defined as any numerical changes other than trisomy (or greater) of chromosome 21.
when we adjusted for gestational age (Table 4) . A 10% increase in birth weight did not appear to be associated with an increased risk of ALL. However, the odds ratio for a 1-standard-deviation (531-g) increase in birth weight, adjusted for gestational age and potential confounding factors, was 1.13 (Table 4) , similar to that observed for a 1-standard-deviation increase in POBW (Table 2) . Similarly, when we treated ''high birth weight'' as a binary variable, the odds ratios for >3,500 g (vs. 3,500 g) and >4,000 g (vs. 4,000 g) were similar to those for a 1-standard-deviation increase in POBW, but only after adjustment for gestational age (Table 4 ). These effect estimates were relatively imprecise.
DISCUSSION
We found a moderately strong and consistent relation between POBW and, by inference, accelerated fetal growth and risk of childhood ALL. Importantly, this association was also present among children who did not have a high birth weight, suggesting that accelerated growth, rather than high birth weight per se, contributes to the cause of ALL. The association we observed between POBW and ALL risk was similar for both sexes, by age at diagnosis, and across most ALL subtypes.
Risk of ALL also increased with increasing birth weight and was elevated for children who had a ''high birth weight,'' but only after adjustment for gestational age. Birth weight indicates the ''final'' fetal weight, whereas POBW is a measure of the appropriateness of fetal growth. In addition to taking account of gestational age, POBW also considers the major nonpathologic determinants of intrauterine growth: fetal sex, maternal height, and parity. Therefore, it could be considered a more informative measure in the assessment of the relation between intrauterine growth and risk of ALL.
However, when it is not possible to calculate POBWfor example, in the absence of information on maternal height or the child's birth order-birth weight adjusted for gestational age and sex appears to be a good proxy.
Similar findings were reported in a recent German study (9) , which investigated the associations between risk of childhood cancers and both birth weight per se and genderspecific birth weight for gestational age. Children who were large for gestational age or had a high birth weight were at an increased risk of ALL. However, an elevated risk of ALL was observed for firstborn children who were large for gestational age but within the normal birth weight range. The authors concluded that investigating birth weight alone could lead to incorrect interpretation of the data.
Three other groups have recently reported positive associations between risk of ALL and birth weight adjusted for gestational age. Hjalgrim et al. (2) found an increased risk of ALL (odds ratio ¼ 1.26, 95% confidence interval: 1.13, 1.41) for every 1-kg increase in birth weight after adjusting for gestational age, birth order, and maternal and paternal ages. Similarly, McLaughlin et al. (8) observed a 25% increase in risk (95% confidence interval: 1.08, 1.43) per kilogram increase in birth weight after adjusting for gestational age, birth year, sex, race, and maternal age. In addition, a US case-cohort study reported a 30% increased risk of ALL (95% confidence interval: 1.07, 1.59) for children who were large for gestational age (10) .
The absence of any apparent association between unadjusted birth weight and ALL risk in our study is at odds with a number of previous studies. One possible explanation is that birth weight may have been more highly correlated with POBW in those studies (had they calculated it) than in ours.
The findings from our case-control study are also consistent with those of our recently published Western Australian population-based data linkage study, in which we observed an increased risk of ALL for children whose intrauterine growth was greater than expected (14) . In this current studyagain similar to our earlier data-linkage study (14)-we did not observe a stronger association among boys than girls or among children younger than age 4 years at diagnosis, as has been reported in some studies of birth weight (7, 9, (16) (17) (18) (19) (20) . Fetal growth in healthy pregnancies is determined by a complex interplay of genetic, nutritional, and hormonal factors (21) . Our results suggest that accelerated fetal growth is associated with an increased risk of childhood ALL, a tenet supported by evidence that both are related to increased levels of insulin-like growth factor I (IGF-I). IGF-I has been shown to be positively associated with birth weight, placental weight, and ponderal index (22) . Many studies, including those considered in a recent review (23) , have reported high circulating levels of IGF-I in infants of high birth weight. Ross et al. (24) also reported 30% higher levels of IGF-I in large-for-gestational-age babies and 40% lower levels in small-for-gestational-age babies, while all 16 studies of birth weight and IGF-I in cord blood or serum cited in the 2006 review reported positive correlations (23) . Similar correlations were also reported by all 7 studies of birth length and IGF-I in cord blood or serum in the 2006 review, and by another study not included in that review (25) . Javaid et al. (22) reported positive associations between IGF-I and infant weight, fat mass, lean mass, and bone mass at birth.
IGF-I also plays a role in normal hematopoiesis (26) (27) (28) . High levels of this factor may increase proliferative stress on the progenitor or preleukemic cells in the bone marrow (13, 24) , thus increasing the number of cell divisions and, in turn, the risk of leukemia. Other evidence exists in support of a role for IGF-I in the pathogenesis of leukemia: 1) IGF-I receptors are present on leukemic lymphoblasts; 2) IGF-I stimulates growth of leukemic cells in vitro (27); 3) IGF-I has been shown to protect hematopoietic cells from apoptosis (29) ; and 4) administration of growth hormone, the effect of which is mediated through the IGF-I system (30) , has been reported to increase risk of childhood acute leukemia (31) . Polymorphisms in the IGF promoter are also known to alter the expression of the IGF gene and are associated with an increased risk of malignancy as a result of the mitogenic and antiapoptotic effects of IGF-I (31, 32).
Our study has strengths and limitations. For reasons described above, examination of the risk of ALL associated with POBW-rather than birth weight per se-represents an advance from previous studies, particularly those that did not adjust for gestational age. Furthermore, POBW was modeled as a continuous variable, obviating the need to assign an arbitrary cutoff for ''high birth weight.'' Previous studies have variously used 3,500 g, 3,800 g, 4,000 g, or the 75th percentile (10) as the cutoff for high birth weight. Such variation makes it difficult to compare results from different studies.
We did not have information on maternal diabetes. Although it is a recognized cause of macrosomia (33) , there is little evidence that it is associated with risk of ALL (14, 34) . We did have information on maternal weight gain during pregnancy; however, it would have been inappropriate to adjust for this factor because it partially measures fetal weight (15) .
As previously indicated, optimal birth weight was estimated by using a nonsmoking population. Although maternal smoking is known to be associated with fetal growth, it was not associated with case-control status in our study, and adjusting for it in our preliminary analyses made no difference in the effect estimate. This finding is consistent with the majority of previous studies that have reported little or no association between maternal smoking and risk of ALL (35, 36) .
To our knowledge, ours is the first study to investigate the association between fetal growth and risk of ALL by disease subtype. Although positive associations-consistent with an increased risk of 15% or more per standard deviation of POBW-were observed in most cytogenetic subgroups, little or no association was observed for cases with hypodiploidy, MLL gene rearrangements, or other numeric changes in chromosomes other than trisomy or greater at chromosome 21. If similar differences by subgroups are confirmed in future studies, they could provide some important leads for studies of underlying biologic mechanisms.
It is well known in epidemiology that, in populationbased case-control studies, families of controls are likely to have a higher socioeconomic status than families of cases (37) , which has the potential to confound the association between exposure and disease if socioeconomic status is also related to the exposure among the controls. We had information on parental education for all participants and on household income for all but 3 cases and 4 controls. Household income was similar for cases and controls and was not associated with POBW among controls. Parents of controls were more likely than parents of cases to have a tertiary education, but parental education was not associated with POBW among the controls. Nonetheless, this variable improved the fit of the analytical models and was included in our analyses.
To maximize response, consenting parents were offered the opportunity to provide information by telephone. Nonetheless, information on maternal height and gestational age was missing for 4% of cases and 35% of controls, precluding their inclusion in this analysis. We have no reason to believe that these variables would differ between responders and nonresponders, and we think it unlikely that our results are biased because of missing data. As shown in Table 1 , mothers of cases were slightly more likely than mothers of controls to provide telephone instead of written information on their height; this factor was therefore adjusted for in the data analysis.
Recall bias is unlikely to have influenced the results of this study. The association between fetal growth and risk of childhood leukemia is not generally known, so any error in the reporting of this variable is likely to be nondifferential between cases and controls. Furthermore, previous studies have shown that mothers generally remember their babies' birth characteristics well, with correlations between medical records and maternal interview being high for both birth weight (r ¼ 0.98) and gestational age (r ¼ 0.86) (38) . Therefore, measurement error in these variables is likely to be small.
The results of this study confirm earlier findings of a positive association between indicators of the rapidity of fetal growth and risk of ALL in childhood and are consistent with a biologically plausible mechanism of accelerated growth associated with higher levels of circulating IGF-I in the fetus. It would be preferable to measure POBW rather than just birth weight in future studies of childhood ALL, because it is more likely to shed light on possible causal pathways.
